ABSTRACT
Tariquidar derivatives have been described as potent and selective ABCG2 inhibitors. However, their susceptibility to hydrolysis limits their applicability. The current study comprises the synthesis and characterization of novel tariquidar-related inhibitors, obtained by bioisosteric replacement of the labile moieties in our previous tariquidar analog UR-ME22-1 (9). CuAAC ("click" reaction) gave convenient access to a triazole core as a substitute for the labile amide group and the labile ester moiety was replaced by different acyl groups in a Sugasawa reaction. A stability assay proved the enhancement of the stability in blood plasma. Compounds UR-MB108 (57) and UR-MB136 (59) inhibited ABCG2 in a Hoechst 33342 transport assay with an IC50 value of about 80 nM and belong to the most potent ABCG2 inhibitors described so far. Compound 57 was highly selective, whereas its PEGylated analog 59 showed some potency at ABCB1. Both 57 and 59 produced an ABCG2 ATPase-depressing effect which is in agreement with our precedent cryo-EM study identifying 59 as an ATPase inhibitor that exerts its effect via locking the inward-facing conformation. Thermostabilization of ABCG2 by 57 and 59 can be taken as a hint to comparable binding to ABCG2. As reference substances, compounds 57 and 59 allow additional mechanistic studies on ABCG2 inhibition. Due to their stability in blood plasma, they are also applicable in vivo. The highly specific inhibitor 57 is suited for PET labeling, helping to further elucidate the (patho)physiological role of ABCG2, e.g. at the BBB.
Subject(s)
ATP Binding Cassette Transporter, Subfamily G, Member 2/antagonists & inhibitors , Neoplasm Proteins/antagonists & inhibitors , Quinolines/pharmacology , Triazoles/pharmacology , ATP Binding Cassette Transporter, Subfamily G, Member 2/metabolism , Dose-Response Relationship, Drug , Humans , KB Cells , MCF-7 Cells , Molecular Structure , Neoplasm Proteins/metabolism , Quinolines/chemical synthesis , Quinolines/chemistry , Structure-Activity Relationship , Triazoles/chemical synthesis , Triazoles/chemistry , Tumor Cells, CulturedABSTRACT
ABCG2 is an ATP-binding cassette (ABC) transporter that protects tissues against xenobiotics, affects the pharmacokinetics of drugs and contributes to multidrug resistance. Although many inhibitors and modulators of ABCG2 have been developed, understanding their structure-activity relationship requires high-resolution structural insight. Here, we present cryo-EM structures of human ABCG2 bound to synthetic derivatives of the fumitremorgin C-related inhibitor Ko143 or the multidrug resistance modulator tariquidar. Both compounds are bound to the central, inward-facing cavity of ABCG2, blocking access for substrates and preventing conformational changes required for ATP hydrolysis. The high resolutions allowed for de novo building of the entire transporter and also revealed tightly bound phospholipids and cholesterol interacting with the lipid-exposed surface of the transmembrane domains (TMDs). Extensive chemical modifications of the Ko143 scaffold combined with in vitro functional analyses revealed the details of ABCG2 interactions with this compound family and provide a basis for the design of novel inhibitors and modulators.
Subject(s)
ATP Binding Cassette Transporter, Subfamily G, Member 2/antagonists & inhibitors , ATP Binding Cassette Transporter, Subfamily G, Member 2/chemistry , Indoles/chemistry , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/chemistry , Quinolines/chemistry , Adenosine Triphosphate/chemistry , Binding Sites , Cholesterol/chemistry , Cryoelectron Microscopy , Diketopiperazines/chemistry , Drug Design , Drug Resistance, Multiple , Drug Screening Assays, Antitumor , Heterocyclic Compounds, 4 or More Rings/chemistry , Humans , Hydrolysis , Kinetics , Lipids/chemistry , Molecular Structure , Phospholipids/chemistry , Protein Binding , Protein Multimerization , Structure-Activity Relationship , Substrate SpecificityABSTRACT
Stimulation of the NTS2 neurotensin receptor causes antipsychotic effects and leads to a promotion of the µ-opioid-independent antinociception, which is important in the modulation of tonic pain sensitivity. We report the synthesis and properties of a small library of peptidic agonists based on the active neurotensin fragment NT(8-13). Two tetrahydrofuran amino acid derivatives were synthesized to replace Tyr11 in NT(8-13). Additionally, Arg8, Arg9, and Ile12 of the lead peptide were exchanged by Lys, Lys, and Gly, respectively. The new compounds showed substantial NTS2 binding affinity and up to 1000-fold selectivity over NTS1. The highest selectivity (Ki(NTS2): 29nM, Ki(NTS1): 35,000nM) was observed for the peptide analog 17Rtrans.
Subject(s)
Furans/pharmacology , Neurotensin/pharmacology , Peptide Fragments/pharmacology , Peptidomimetics/pharmacology , Pyrrolidonecarboxylic Acid/analogs & derivatives , Receptors, Neurotensin/agonists , Animals , Binding Sites , CHO Cells , Cricetulus , Furans/chemical synthesis , Furans/chemistry , HEK293 Cells , Humans , Molecular Conformation , Molecular Dynamics Simulation , Molecular Mimicry , Neurotensin/chemical synthesis , Neurotensin/chemistry , Peptide Fragments/chemical synthesis , Peptide Fragments/chemistry , Peptidomimetics/chemical synthesis , Peptidomimetics/chemistry , Pyrrolidonecarboxylic Acid/chemical synthesis , Pyrrolidonecarboxylic Acid/chemistry , Pyrrolidonecarboxylic Acid/pharmacologyABSTRACT
ABC, it's easy as 1 2 3! Bioisosteric replacement of the anilide core by an indole moiety considerably increased stability and gave potent and selective ABCG2 (BCRP) inhibitors. Some compounds are superior to the reference substances fumitremorginâ C and Ko143 in terms of potency and efficacy and are the most potent ABCG2 modulators reported so far.
